Tag: Marie-France Tschudin

Novartis to acquire ocular gene therapy company Gyroscope Therapeutics

pallavi123- January 3, 2022

Novartis has agreed to acquire Gyroscope Therapeutics, a UK-based ocular gene therapy company, in a deal worth up to $1.5 billion. As per the terms ... Read More

Novartis bags Kesimpta FDA approval for relapsing forms of MS

pharmanewsdaily- August 21, 2020

Kesimpta FDA approval for RMS: Novartis has bagged approval from the US Food and Drug Administration (FDA) for its blood cancer drug Kesimpta (ofatumumab, formerly OMB157) ... Read More

Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran

pharmanewsdaily- November 25, 2019

Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire US biopharma company The Medicines Company, as ... Read More

Novartis bags Beovu FDA approval for wet AMD

pharmanewsdaily- October 9, 2019

Beovu FDA approval for wet AMD : Swiss pharma giant Novartis has been given approval from the US Food and Drug Administration (FDA) for Beovu ... Read More